Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Mental Health Services Providers (US)(?)

Council Members in this Study Group: 286

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Rami Kaminski, MD
Founder and Director
Institute for Integrative Psychiatry

Rami Kaminski, MD, is Director and Founder of the Institute for Integrative Psychiatry in New York, a not-for-profit organization aimed at evaluating current psychiatric services and how they integrate with medicine, such as the mutual effects between medical and psychiatric conditions. Prior to that,...

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
February 26, 2008
THe hoopla is premature

The clinical trial which was done has shown only comparable efficacy to available treatment for positive symptoms.  It did not study efficacy for cognition or negative symptoms.  It did not test efficacy in treatment resistant patients. It did not show long term efficacy. It did not show that...

My clinical experience with Tenex (guanfacine) was that it was most effective as an add-on treatment for ADHD with associated aggressive behavior. I expect that Intuniv will have the same efficacy limitations. Nonetheless, Intuniv's ease of use and tolerability along with FDA approval should...

Analysis of: Over-The-Counter Weight Loss Drug Approved | abclocal.go.com

Alli faces many difficulties in the marketplace which will limit sales in the long run and which may lead to litigation and FDA withdrawal.

Analysis of: PHR data overload, legal liability concern docs | modernhealthcare.com

I believe the PHRs will be of a net benefit because a physician's job is to deal with information from multiple sources and then formulate an intellectual assessment and recommendation.  I believe part of the problem with this issue is:  How do we say no to a patient?  We as physicians...

Analysis of: Retail clinics: Accepting the inevitable | www.fiercehealthcare.com

The article brought up several unique ideas in dealing with this new trend.  Being in primary care myself, it feels like a kick in the gut when I get a report from "MinuteClinic" for one of my patients -- I immediatly check the time and date to see if our office was open at that time.  Our...

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Non-Academic Community Hospital or Clinic
  • Government/Military Hospital or Clinic
  • Facility, Government/Public Hospital
  • Facility, Non-Academic/Community Hospital
  • Addiction Rehabilitation Center
  • Other Freestanding Healthcare Facility

Most Common Job Types:

  • Physician - Attending Physician
  • Director
  • Owner
  • Physician - Director
  • Chief Executive Officer
  • Allied Health Professional
  • Medical Director
  • Physician - Department Chair
  • Consultant
  • Manager
  • President

GLG's 850+ Clients Include:

Fortune 500®  companies
40 of the leading 50  global mutual funds
15 of the leading 20  global banks
8 of the leading 10  global private equity firms
5 of the top 10  AmLaw firms

Analytics


Generated at 2009-01-08T19:00:17.880